US4921794A
(en)
*
|
1987-01-14 |
1990-05-01 |
President And Fellows Of Harvard College |
T7 DNA polymerase
|
US4942130A
(en)
*
|
1987-01-14 |
1990-07-17 |
President & Fellows Of Harvard College |
T7 DNA polymerase
|
US4946786A
(en)
*
|
1987-01-14 |
1990-08-07 |
President And Fellows Of Harvard College |
T7 DNA polymerase
|
US5266466A
(en)
*
|
1987-01-14 |
1993-11-30 |
President And Fellows Of Harvard College |
Method of using T7 DNA polymerase to label the 3' end of a DNA molecule
|
US5145776A
(en)
*
|
1987-01-14 |
1992-09-08 |
President & Fellows Of Harvard College |
Method of using T7 DNA polymerase to mutagenize and fill-in DNA
|
US4994372A
(en)
*
|
1987-01-14 |
1991-02-19 |
President And Fellows Of Harvard College |
DNA sequencing
|
EP0317239A3
(en)
*
|
1987-11-13 |
1990-01-17 |
Native Plants Incorporated |
Method and device for improved restriction fragment length polymorphism analysis
|
US5244797B1
(en)
*
|
1988-01-13 |
1998-08-25 |
Life Technologies Inc |
Cloned genes encoding reverse transcriptase lacking rnase h activity
|
US5498523A
(en)
*
|
1988-07-12 |
1996-03-12 |
President And Fellows Of Harvard College |
DNA sequencing with pyrophosphatase
|
US4962020A
(en)
*
|
1988-07-12 |
1990-10-09 |
President And Fellows Of Harvard College |
DNA sequencing
|
US5075216A
(en)
*
|
1988-09-23 |
1991-12-24 |
Cetus Corporation |
Methods for dna sequencing with thermus aquaticus dna polymerase
|
US5142033A
(en)
*
|
1988-09-23 |
1992-08-25 |
Hoffmann-La Roche Inc. |
Structure-independent DNA amplification by the polymerase chain reaction
|
US5091310A
(en)
*
|
1988-09-23 |
1992-02-25 |
Cetus Corporation |
Structure-independent dna amplification by the polymerase chain reaction
|
WO1990008839A1
(en)
*
|
1989-02-06 |
1990-08-09 |
Eastman Kodak Company |
Thermostable polymerase dna sequencing reaction concentrate
|
US5001050A
(en)
*
|
1989-03-24 |
1991-03-19 |
Consejo Superior Investigaciones Cientificas |
PHφ29 DNA polymerase
|
US5198543A
(en)
*
|
1989-03-24 |
1993-03-30 |
Consejo Superior Investigaciones Cientificas |
PHI29 DNA polymerase
|
US5045450A
(en)
*
|
1989-07-13 |
1991-09-03 |
Massachusetts Institute Of Technology |
Determination of a mutational spectrum
|
US5541099A
(en)
*
|
1989-08-10 |
1996-07-30 |
Life Technologies, Inc. |
Cloning and expression of T5 DNA polymerase reduced in 3'-to-5' exonuclease activity
|
US5270179A
(en)
*
|
1989-08-10 |
1993-12-14 |
Life Technologies, Inc. |
Cloning and expression of T5 DNA polymerase reduced in 3'- to-5' exonuclease activity
|
US5047342A
(en)
*
|
1989-08-10 |
1991-09-10 |
Life Technologies, Inc. |
Cloning and expression of T5 DNA polymerase
|
FR2650840B1
(fr)
*
|
1989-08-11 |
1991-11-29 |
Bertin & Cie |
Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications
|
DE4214112A1
(de)
*
|
1991-08-02 |
1993-02-04 |
Europ Lab Molekularbiolog |
Neues verfahren zur sequenzierung von nukleinsaeuren
|
US5756285A
(en)
*
|
1991-09-27 |
1998-05-26 |
Amersham Life Science, Inc. |
DNA cycle sequencing
|
US5674679A
(en)
*
|
1991-09-27 |
1997-10-07 |
Amersham Life Science, Inc. |
DNA cycle sequencing
|
US5869282A
(en)
|
1991-12-11 |
1999-02-09 |
Imperial Cancer Research Technology, Ltd. |
Nucleotide and protein sequences of the serrate gene and methods based thereon
|
US5830642A
(en)
*
|
1992-04-03 |
1998-11-03 |
Amersham Life Science, Inc. |
Electrophoresis of nucleic acid fragments
|
US5314595A
(en)
*
|
1992-04-03 |
1994-05-24 |
United States Biochemical Corporation |
Electrophoresis of nucleic acid fragments
|
US5401632A
(en)
*
|
1992-07-16 |
1995-03-28 |
Wisconsin Alumni Research Foundation |
Triple helix purification and sequencing
|
US5424190A
(en)
*
|
1992-10-13 |
1995-06-13 |
United States Biochemical Corporation |
Method for using amide-containing stop solution
|
EP0682671A4
(en)
*
|
1993-02-01 |
1998-01-14 |
Seq Ltd |
METHOD AND DEVICES FOR SEQUENCING DNA.
|
US7465539B1
(en)
|
1993-02-19 |
2008-12-16 |
Takara Bio, Inc. |
DNA polymerases with enhanced length of primer extension
|
US5436149A
(en)
*
|
1993-02-19 |
1995-07-25 |
Barnes; Wayne M. |
Thermostable DNA polymerase with enhanced thermostability and enhanced length and efficiency of primer extension
|
US6410277B1
(en)
|
1993-02-19 |
2002-06-25 |
Takara Shuzo Co., Ltd. |
DNA polymersases with enhanced length of primer extension
|
US5500339A
(en)
*
|
1993-03-30 |
1996-03-19 |
Amersham Life Science, Inc. |
DNA denaturation method
|
WO1994023066A1
(en)
*
|
1993-03-30 |
1994-10-13 |
United States Biochemical Corporation |
Use of exonuclease in dna sequencing
|
US7312052B1
(en)
|
1993-12-08 |
2007-12-25 |
Stratagene California |
Polymerase compositions and uses thereof
|
US6335160B1
(en)
|
1995-02-17 |
2002-01-01 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
US6406855B1
(en)
|
1994-02-17 |
2002-06-18 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
USH1531H
(en)
*
|
1994-04-18 |
1996-05-07 |
Blumentals; Ilse I. |
Thermophilic DNA polymerase
|
US6015668A
(en)
*
|
1994-09-30 |
2000-01-18 |
Life Technologies, Inc. |
Cloned DNA polymerases from thermotoga and mutants thereof
|
US5912155A
(en)
|
1994-09-30 |
1999-06-15 |
Life Technologies, Inc. |
Cloned DNA polymerases from Thermotoga neapolitana
|
US5614365A
(en)
*
|
1994-10-17 |
1997-03-25 |
President & Fellow Of Harvard College |
DNA polymerase having modified nucleotide binding site for DNA sequencing
|
US5545539A
(en)
*
|
1994-10-18 |
1996-08-13 |
Genzyme Corporation |
Method for nucleotide sequence amplification
|
EP1985703A3
(en)
|
1994-11-02 |
2009-04-08 |
Allelix Neuroscience, Inc. |
Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
|
IL114615A0
(en)
|
1995-07-16 |
1995-11-27 |
Yeda Res & Dev |
Modulators of the function of fas receptors and other proteins
|
CA2222744C
(en)
*
|
1995-05-31 |
2008-03-25 |
Amersham Life Science, Inc. |
Thermostable dna polymerases
|
AU723939B2
(en)
|
1995-06-28 |
2000-09-07 |
Imperial Cancer Research Technology Ltd |
Nucleotide and protein sequences of vertebrate delta genes and methods based thereon
|
US5888736A
(en)
*
|
1995-12-22 |
1999-03-30 |
Visible Genetics, Inc. |
Method, compositions and kit for detection and identification of microorganisms
|
US5789168A
(en)
*
|
1996-05-01 |
1998-08-04 |
Visible Genetics Inc. |
Method for amplification and sequencing of nucleic acid polymers
|
US5830657A
(en)
*
|
1996-05-01 |
1998-11-03 |
Visible Genetics Inc. |
Method for single-tube sequencing of nucleic acid polymers
|
US5972603A
(en)
*
|
1996-02-09 |
1999-10-26 |
President And Fellows Of Harvard College |
DNA polymerase with modified processivity
|
US6413718B1
(en)
|
1996-05-01 |
2002-07-02 |
Visible Genetics Inc. |
Method for sequencing of nucleic acid polymers
|
US6083699A
(en)
*
|
1996-05-01 |
2000-07-04 |
Visible Genetics Inc. |
Method for bi-directional sequencing of nucleic acid polymers
|
US6214555B1
(en)
|
1996-05-01 |
2001-04-10 |
Visible Genetics Inc. |
Method compositions and kit for detection
|
EP2264045B1
(en)
|
1996-08-14 |
2015-10-21 |
Life Technologies Corporation |
Stable compositions for nucleic acid amplification and sequencing
|
US6291164B1
(en)
|
1996-11-22 |
2001-09-18 |
Invitrogen Corporation |
Methods for preventing inhibition of nucleic acid synthesis by pyrophosphate
|
US6306588B1
(en)
*
|
1997-02-07 |
2001-10-23 |
Invitrogen Corporation |
Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof
|
EP2208789B1
(en)
|
1997-03-12 |
2015-07-22 |
Applied Biosystems, LLC |
DNA polymerases having improved labeled nucleotide incorporation properties
|
CA2283635A1
(en)
|
1997-03-21 |
1998-10-01 |
Stratagene |
Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying
|
DE69842183D1
(de)
|
1997-08-29 |
2011-04-28 |
Life Technologies Corp |
Hochempfindliche polymerasen und ihre verwendungen
|
IL135776A0
(en)
*
|
1997-10-24 |
2001-05-20 |
Life Technologies Inc |
Recombinational cloning using nucleic acids having recombination sites
|
US6057106A
(en)
*
|
1998-01-23 |
2000-05-02 |
Novex |
Sample buffer and methods for high resolution gel electrophoresis of denatured nucleic acids
|
US6787305B1
(en)
|
1998-03-13 |
2004-09-07 |
Invitrogen Corporation |
Compositions and methods for enhanced synthesis of nucleic acid molecules
|
CA2367906A1
(en)
*
|
1999-03-15 |
2000-09-21 |
Thomas Jefferson University |
Tcl-1b gene and protein and related methods and compositions
|
US6630333B1
(en)
*
|
1999-03-23 |
2003-10-07 |
Invitrogen Corporation |
Substantially pure reverse transriptases and methods of production thereof
|
JP2002543795A
(ja)
*
|
1999-05-12 |
2002-12-24 |
インビトロゲン・コーポレーション |
核酸合成の感度および特異性の増大のための組成物および方法
|
US7056661B2
(en)
*
|
1999-05-19 |
2006-06-06 |
Cornell Research Foundation, Inc. |
Method for sequencing nucleic acid molecules
|
US6376210B1
(en)
|
1999-07-06 |
2002-04-23 |
General Atomics |
Methods and compositions for assaying analytes
|
US7192729B2
(en)
|
1999-07-06 |
2007-03-20 |
General Atomics |
Methods for assaying homocysteine
|
AU2001227679A1
(en)
*
|
2000-02-25 |
2001-09-03 |
General Atomics |
Mutant nucleic binding enzymes and use thereof in diagnostic, detection and purification methods
|
US6610504B1
(en)
|
2000-04-10 |
2003-08-26 |
General Atomics |
Methods of determining SAM-dependent methyltransferase activity using a mutant SAH hydrolase
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
US7198924B2
(en)
|
2000-12-11 |
2007-04-03 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
DE60138714D1
(de)
*
|
2000-10-11 |
2009-06-25 |
Applera Corp |
Fluoreszierende nukleobasekonjugate mit anionische linker
|
WO2002086088A2
(en)
*
|
2001-04-24 |
2002-10-31 |
Li-Cor, Inc. |
Polymerases with charge-switch activity and methods of generating such polymerases
|
EP2354156A3
(en)
|
2001-08-14 |
2011-11-16 |
Sentigen Biosciences, Inc. |
Nucleic acids and proteins of insect OR83B odorant receptor genes and uses thereof
|
US7256019B2
(en)
*
|
2001-08-29 |
2007-08-14 |
Ge Healthcare Bio-Sciences Corp. |
Terminal phosphate blocked nucleoside polyphosphates
|
EP1436385A4
(en)
*
|
2001-09-14 |
2005-12-14 |
Invitrogen Corp |
DNA POLYMERASES AND MUTANTS CORRESPONDING
|
US20050042629A1
(en)
|
2002-09-13 |
2005-02-24 |
Applera Corporation |
Thermus scotoductus nucleic acid polymerases
|
WO2004039826A1
(en)
|
2001-11-14 |
2004-05-13 |
Centocor, Inc. |
Anti-il-6 antibodies, compositions, methods and uses
|
US7222059B2
(en)
*
|
2001-11-15 |
2007-05-22 |
Siemens Medical Solutions Diagnostics |
Electrophoretic trace simulator
|
US7052877B2
(en)
|
2001-11-30 |
2006-05-30 |
Applera Corporation |
Thermus brockianus nucleic acid polymerases
|
US20030228589A1
(en)
*
|
2002-02-12 |
2003-12-11 |
Bond-Nutter Diane R. |
Polymerase compositions
|
EP1543128A4
(en)
*
|
2002-07-18 |
2008-02-20 |
Invitrogen Corp |
VIRUS VECTORS WITH RECOMBINATION SITES
|
WO2004087868A2
(en)
|
2003-03-25 |
2004-10-14 |
Stratagene |
Dna polymerase fusions and uses thereof
|
US9708410B2
(en)
|
2003-05-30 |
2017-07-18 |
Janssen Biotech, Inc. |
Anti-tissue factor antibodies and compositions
|
DE602004027538D1
(de)
*
|
2003-12-01 |
2010-07-15 |
Life Technologies Corp |
Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
|
WO2006028496A2
(en)
*
|
2004-02-20 |
2006-03-16 |
Applera Corporation |
Lesion repair polymerase compositions
|
US7384760B2
(en)
*
|
2004-04-30 |
2008-06-10 |
General Atomics |
Methods for assaying inhibitors of S-adenosylhomocysteine (SAH) hydrolase and S-adenosylmethionine (SAM)-dependent methyltransferase
|
US20050282155A1
(en)
*
|
2004-06-17 |
2005-12-22 |
Lucigen Corporation |
Viral libraries from uncultivated viruses and polypeptides produced therefrom
|
PE20061324A1
(es)
|
2005-04-29 |
2007-01-15 |
Centocor Inc |
Anticuerpos anti-il-6, composiciones, metodos y usos
|
US20060292578A1
(en)
*
|
2005-06-28 |
2006-12-28 |
Weidong Zheng |
DNA polymerase blends and mutant DNA polymerases
|
AU2006265002B2
(en)
|
2005-06-30 |
2012-09-20 |
Centocor, Inc. |
Anti-IL-23 antibodies, compositions, methods and uses
|
US8093030B2
(en)
*
|
2005-10-06 |
2012-01-10 |
Lucigen Corporation |
Thermostable viral polymerases and methods of use
|
HUE034269T2
(en)
|
2005-12-29 |
2018-02-28 |
Janssen Biotech Inc |
Human anti-IL-23 antibodies, preparations, methods and applications
|
US20080118914A1
(en)
*
|
2006-01-04 |
2008-05-22 |
Charlotte Dawn Blowe |
Follistatin gene as a genetic marker for first parity litter size in pigs
|
US20070186298A1
(en)
*
|
2006-01-04 |
2007-08-09 |
Blowe Charlotte D |
Follistatin gene as a genetic marker for reproductive and performance traits in pigs
|
MX2011001409A
(es)
|
2008-08-14 |
2011-03-29 |
Cephalon Australia Pty Ltd |
Anticuerpos anti-il-12/il-23.
|
MX2011004550A
(es)
|
2008-10-31 |
2011-07-20 |
Centocor Ortho Biotech Inc |
Composiciones de de supercóntigos a base de dominios de fibronectina tipo iii, métodos y usos.
|
JP5873335B2
(ja)
|
2009-02-12 |
2016-03-01 |
ヤンセン バイオテツク,インコーポレーテツド |
フィブロネクチンiii型ドメインに基づくスカフォールド組成物、方法及び使用
|
PE20130192A1
(es)
|
2010-03-30 |
2013-02-27 |
Centocor Ortho Biotech Inc |
Anticuerpos il-25 humanizados
|
EP3961214A1
(en)
|
2010-12-31 |
2022-03-02 |
BioAtla, Inc. |
Comprehensive monoclonal antibody generation
|
AU2011352205B2
(en)
|
2010-12-31 |
2016-06-16 |
Bioatla, Llc |
Express humanization of antibodies
|
EP3257952B1
(en)
|
2012-09-11 |
2020-02-12 |
Life Technologies Corporation |
Nucleic acid amplification
|
WO2014043143A1
(en)
|
2012-09-11 |
2014-03-20 |
Life Technologies Corporation |
Nucleic acid amplification
|
US10119134B2
(en)
|
2013-03-15 |
2018-11-06 |
Abvitro Llc |
Single cell bar-coding for antibody discovery
|
WO2016011280A1
(en)
|
2014-07-16 |
2016-01-21 |
Tangen Biosciences, Inc. |
Isothermal methods for amplifying nucleic acid samples
|
SG11201702060VA
(en)
|
2014-09-15 |
2017-04-27 |
Abvitro Inc |
High-throughput nucleotide library sequencing
|
EP3215260B1
(en)
|
2014-11-03 |
2020-01-15 |
Tangen Biosciences Inc. |
Apparatus and method for cell, spore, or virus capture and disruption
|
BR112018069776A2
(pt)
|
2016-03-29 |
2019-02-05 |
Janssen Biotech Inc |
tratamento de psoríase com intervalo de dosagem aumentado de anticorpos anti-il-12 e/ou anti-il-23
|
AU2017296237A1
(en)
|
2016-07-15 |
2019-01-03 |
Poseida Therapeutics, Inc. |
Chimeric antigen receptors (CARS) specific for MUC1 and methods for their use
|
MX2019000643A
(es)
|
2016-07-15 |
2019-06-13 |
Poseida Therapeutics Inc |
Receptores de antigenos quimericos y metodos de uso.
|
JP2020500152A
(ja)
|
2016-09-30 |
2020-01-09 |
ヤンセン バイオテツク,インコーポレーテツド |
抗il23特異的抗体で乾癬を治療する安全かつ有効な方法
|
IL265664B2
(en)
|
2016-10-06 |
2024-02-01 |
Poseida Therapeutics Inc |
Inducible caspases and methods of use
|
EP3541422A4
(en)
|
2016-11-16 |
2020-05-06 |
Janssen Biotech, Inc. |
METHOD FOR TREATING PSORIASIS WITH A SPECIFIC ANTI-IL-23 ANTIBODY
|
MA47362A
(fr)
|
2017-01-30 |
2019-12-04 |
Janssen Biotech Inc |
Anticorps anti-tnf, compositions et méthodes pour le traitement du rhumatisme psoriasique actif
|
MA47442A
(fr)
|
2017-02-07 |
2019-12-18 |
Janssen Biotech Inc |
Anticorps anti-tnf, compositions et méthodes pour le traitement de la spondylarthrite ankylosante active
|
CA3056227A1
(en)
|
2017-03-13 |
2018-09-20 |
Poseida Therapeutics, Inc. |
Compositions and methods for selective elimination and replacement of hematopoietic stem cells
|
EP3631012B1
(en)
|
2017-05-26 |
2022-06-08 |
AbVitro LLC |
High-throughput polynucleotide library sequencing and transcriptome analysis
|
KR20200023455A
(ko)
|
2017-06-30 |
2020-03-04 |
코덱시스, 인코포레이티드 |
T7 rna 폴리머라제 변이체
|
US10738286B2
(en)
|
2017-06-30 |
2020-08-11 |
Codexis, Inc. |
T7 RNA polymerase variants
|
EP3679370A1
(en)
|
2017-09-07 |
2020-07-15 |
Juno Therapeutics, Inc. |
Methods of identifying cellular attributes related to outcomes associated with cell therapy
|
WO2019051424A2
(en)
|
2017-09-08 |
2019-03-14 |
Poseida Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR CONDITIONAL GENE EXPRESSION MEDIATED BY A CHIMERIC LIGAND RECEPTOR (CLR)
|
TW201922780A
(zh)
|
2017-09-25 |
2019-06-16 |
美商健生生物科技公司 |
以抗il12/il23抗體治療狼瘡之安全且有效之方法
|
BR112020012555A2
(pt)
|
2017-12-20 |
2020-11-24 |
Poseida Therapeutics, Inc. |
composições de vcar e métodos para uso
|
EP3762015A4
(en)
|
2018-03-05 |
2022-04-27 |
Janssen Biotech, Inc. |
METHODS OF TREATING CROHN'S DISEASE WITH SPECIFIC ANTI-IL23 ANTIBODY
|
CA3092947A1
(en)
|
2018-03-07 |
2019-09-12 |
Poseida Therapeutics, Inc. |
Cartyrin compositions and methods for use
|
EP3824295A4
(en)
|
2018-07-18 |
2022-04-27 |
Janssen Biotech, Inc. |
PREDICTORS OF PROLONGED RESPONSE AFTER TREATMENT WITH AN ANTI-IL23 SPECIFIC ANTIBODY
|
JP2021536249A
(ja)
|
2018-09-05 |
2021-12-27 |
ポセイダ セラピューティクス,インコーポレイティド |
同種異系細胞組成物およびその使用方法
|
KR20210093973A
(ko)
|
2018-11-20 |
2021-07-28 |
얀센 바이오테크 인코포레이티드 |
항-il23 특이적 항체로 건선을 치료하는 안전하고 효과적인 방법
|
MA54562A
(fr)
|
2018-12-18 |
2021-10-27 |
Janssen Biotech Inc |
Méthode sûre et efficace de traitement du lupus avec un anticorps anti-il12/il23
|
EP3898993A1
(en)
|
2018-12-20 |
2021-10-27 |
Poseida Therapeutics, Inc. |
Nanotransposon compositions and methods of use
|
WO2020148651A1
(en)
|
2019-01-15 |
2020-07-23 |
Janssen Biotech, Inc. |
Anti-tnf antibody compositions and methods for the treatment of juvenile idiopathic arthritis
|
EP3914618A1
(en)
|
2019-01-23 |
2021-12-01 |
Janssen Biotech, Inc. |
Anti-tnf antibody compositions for use in methods for the treatment of psoriatic arthritis
|
EP3938390A1
(en)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
EP3938391A1
(en)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech, Inc. |
Methods for producing anti-tnf antibody compositions
|
KR20210141990A
(ko)
|
2019-03-14 |
2021-11-23 |
얀센 바이오테크 인코포레이티드 |
항-il12/il23 항체 조성물을 생성하기 위한 제조 방법
|
KR20210141998A
(ko)
|
2019-03-14 |
2021-11-23 |
얀센 바이오테크 인코포레이티드 |
항-tnf 항체 조성물의 제조 방법
|
BR112021023295A2
(pt)
|
2019-05-23 |
2022-02-08 |
Janssen Biotech Inc |
Método de tratamento de doença inflamatória intestinal com uma terapia de combinação de anticorpos para il-23 e tnf-alfa
|
EP3976648A1
(en)
|
2019-06-03 |
2022-04-06 |
Janssen Biotech, Inc. |
Anti-tnf antibody compositions, and methods for the treatment of psoriatic arthritis
|
US20220324959A1
(en)
|
2019-06-03 |
2022-10-13 |
Janssen Biotech, Inc. |
Anti-tnf antibodies, compositions, and methods for the treatment of active ankylosing spondylitis
|
WO2021028752A1
(en)
|
2019-08-15 |
2021-02-18 |
Janssen Biotech, Inc. |
Anti-tfn antibodies for treating type i diabetes
|
WO2021046261A1
(en)
|
2019-09-05 |
2021-03-11 |
Poseida Therapeutics, Inc. |
Allogeneic cell compositions and methods of use
|
JP2023510121A
(ja)
|
2019-12-20 |
2023-03-13 |
ポセイダ セラピューティクス,インコーポレイティド |
抗Muc1組成物及び使用方法
|
KR20220149588A
(ko)
|
2020-03-04 |
2022-11-08 |
포세이다 테라퓨틱스, 인크. |
대사성 간 장애의 치료를 위한 조성물 및 방법
|
US20230121433A1
(en)
|
2020-03-11 |
2023-04-20 |
Poseida Therapeutics, Inc. |
Chimeric stimulatory receptors and methods of use in t cell activation and differentiation
|
CA3174777A1
(en)
|
2020-04-14 |
2021-10-21 |
Eric M. Ostertag |
Compositions and methods for use in the treatment of cancer
|
EP4231999A1
(en)
|
2020-10-21 |
2023-08-30 |
Poseida Therapeutics, Inc. |
Compositions and methods for delivery of nucleic acids
|
US20240189446A1
(en)
|
2021-02-23 |
2024-06-13 |
Poseida Therapeutics, Inc. |
Compositions and methods for delivery of nucleic acids
|
WO2022182797A1
(en)
|
2021-02-23 |
2022-09-01 |
Poseida Therapeutics, Inc. |
Genetically modified induced pluripotent stem cells and methods of use thereof
|
WO2022187671A1
(en)
|
2021-03-04 |
2022-09-09 |
Poseida Therapeutics, Inc. |
Compositions and methods for the treatment of hemophilia
|
KR20230156387A
(ko)
|
2021-03-12 |
2023-11-14 |
얀센 바이오테크 인코포레이티드 |
항-il23 특이적 항체에 의해 건선성 관절염을 치료하는 안전하고 효과적인 방법
|
WO2022190034A1
(en)
|
2021-03-12 |
2022-09-15 |
Janssen Biotech, Inc. |
Method of treating psoriatic arthritis patients with inadequate response to tnf therapy with anti-il23 specific antibody
|
KR20240034218A
(ko)
|
2021-07-09 |
2024-03-13 |
얀센 바이오테크 인코포레이티드 |
항-tnf 항체 조성물을 생산하기 위한 제조 방법
|
CN117916260A
(zh)
|
2021-07-09 |
2024-04-19 |
詹森生物科技公司 |
用于制备抗il12/il23抗体组合物的制造方法
|
EP4367137A1
(en)
|
2021-07-09 |
2024-05-15 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
WO2023060088A1
(en)
|
2021-10-04 |
2023-04-13 |
Poseida Therapeutics, Inc. |
Transposon compositions and methods of use thereof
|
KR20240099249A
(ko)
|
2021-10-04 |
2024-06-28 |
포세이다 테라퓨틱스, 인크. |
트랜스포사제 및 이의 용도
|
KR20240099352A
(ko)
|
2021-10-29 |
2024-06-28 |
얀센 바이오테크 인코포레이티드 |
항-il23 특이적 항체로 크론병을 치료하는 방법
|
CA3238377A1
(en)
|
2021-11-15 |
2023-05-19 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
AU2022396102A1
(en)
|
2021-11-23 |
2024-07-11 |
Janssen Biotech, Inc. |
Method of treating ulcerative colitis with anti-il23 specific antibody
|
WO2023141576A1
(en)
|
2022-01-21 |
2023-07-27 |
Poseida Therapeutics, Inc. |
Compositions and methods for delivery of nucleic acids
|
WO2023164573A1
(en)
|
2022-02-23 |
2023-08-31 |
Poseida Therapeutics, Inc. |
Genetically modified cells and methods of use thereof
|
US20230374122A1
(en)
|
2022-05-18 |
2023-11-23 |
Janssen Biotech, Inc. |
Method for Evaluating and Treating Psoriatic Arthritis with IL23 Antibody
|
US20240199734A1
(en)
|
2022-11-22 |
2024-06-20 |
Janssen Biotech, Inc. |
Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody
|